Regional Cancer Care Associates logo

Regional Cancer Care Associates

North America, New Jersey, United States, Hackensack

Description

Regional Cancer Care Associates (RCCA) is one of the largest oncology oncology physician networks in the United States

Investor Profile

Regional Cancer Care Associates has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Artificial Intelligence (AI), Biotechnology, Health Care.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Health Care
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Regional Cancer Care Associates frequently co-invest with?

dRx Capital
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 1
Novartis
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Foundation Medicine
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Horizon Blue Cross Blue Shield of New Jersey
North America, New Jersey, United States, Newark
Co-Investments: 1
Med-Metrix
North America, New Jersey, United States, Parsippany
Co-Investments: 1

What are some of recent deals done by Regional Cancer Care Associates?

COTA Healthcare

New York, New York, United States

Bringing clarity to cancer. Working to ensure that everyone touched by cancer has a clear path to the right care.

Artificial Intelligence (AI)BiotechnologyHealth CareLife Science
Series BMay 24, 2016